Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
at least 18 years old
confirmed diagnosis of EGFR mutation-positive NSCLC
at least one measurable intracranial metastasis
ECOG-PS of 0, 1 or 2
dacomitinib as first-line treatment for advanced NSCLC
Evidence of a personally signed and dated informed consent document (ICD)
You may not be if
any anti-cancer systemic treatment within 12 months prior to index date
currently on active investigational drug(s) treatment in other clinical studies (Phase 1-4) within 2 weeks before the current study begins and/or during study participation.